Jun. 24, 2025 — GE HealthCare has announced that the U.S. Food and Drug Administration (FDA) approved an updated label for its positron emission tomography (PET) imaging agent Vizamyl (flutemetamol F 18 injection) for beta-amyloid detection.
Nuclear Imaging
Molecular imaging, also called nuclear imaging, includes positron emission computed tomography (PET) and single photon emission computed tomography (SPECT) imaging. This section includes radiopharmaceuticals and tracers, PET-CT, SPECT-CT, and PET-MRI.
Jun. 24, 2025 — GE HealthCare has announced that the U.S. Food and Drug Administration (FDA) approved an updated label ...
June 19, 2025 – dGenThera, Inc., a biotechnology company pioneering theranostic molecular pairs, and Nusano, a physics ...
June 23, 2025 — GE HealthCare’s commitment to advancing precision care in cardiology through its molecular imaging ...
Efficiency and effectiveness are inseparable in clinical medicine. Digital PET addresses them both. The key is the ...
June 23, 2025 — Serac Imaging Systems Ltd. and its clinical investigators from The Ohio State University Wexner Medical ...
June 19, 2025 — Building on a collaboration that spans more than three decades, GE HealthCare has renewed its research ...
May 30, 2025 — GE HealthCare recently announced that the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) ...
May 5, 2025 — GE HealthCare recently announced that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance ...
April 2, 2025 — Patients for Safer Nuclear Medicine (PSNM), a coalition of 30 non-profit organizations advocating on ...
Feb. 5, 2025 — Serac Healthcare Ltd., a clinical radiopharmaceutical company developing an innovative molecular imaging ...
Jan. 30, 2025 – Earlier this month, the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the Alzheimer’s ...
Jan. 24, 2025 —The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the European Association of Nuclear ...
Jan. 8, 2025 – The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the Alzheimer’s Association have ...
Dec. 2, 2024 — GE HealthCare has agreed to acquire full ownership of Nihon Medi-Physics Co., Ltd (NMP), by purchasing ...
Nov. 25, 2024 — GE HealthCare has announced it is woking with Peter MacCallum Cancer Centre in Melbourne, Australia, to ...
Nov. 1, 2024 — The Centers for Medicare & Medicaid Services (CMS) have announced a significant adjustment to the ...
Oct. 21, 2024 — Siemens Healthineers recently received Food and Drug Administration clearance for two new features in ...
A major update was made to the International Nuclear Workers Study (INWORKS), an international epidemiological study of ...
Aug. 28, 2024 – AC Immune SA recently announced that its partner Life Molecular Imaging (LMI) has received Fast Track ...
July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...
July 30, 2024 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization ...